The increased use of the CT scanner in the investigation of patients with cerebrovascular disease has led to more frequent recognition of strokes caused by intracerebral haemorrhage (ICH). The diagnosis is being made at both extremes of the clinical spectrum. At one end are patients in coma with an extremely poor prognosis who, in the past, would have been considered on clinical grounds to have an intracerebral haemorrhage. At the other are patients with only minor focal neurological deficits, who were previously regarded as having suffered an ischaemic episode and therefore were not investigated by CT scanning.
The inaccuracy of diagnosis in the past is one reason that the choice of treatment remains very controversial. The debate should be advanced by the changing use of CT and the greater awareness of the smaller lesion. Previous trials of surgical treatment, even when randomised and controlled, have failed to match patient groups for the size of the clot and have resulted in further confusion. Any form of treatment is likely to be more successful with smaller haemorrhages. Unnecessary surgical evacuation of small clots may be followed by a good result, while the outcome of surgery for very large lesions in deeply comatose patients will be poor. ' Intracerebral haemorrhage is relatively common (20 per 100 000 per year) and, with subarachnoid haemorrhage (10 per 100 000 per year), accounts for 15% of all strokes. While there are now more than 137 CT scanners in the United Kingdom, their distribution is very uneven,2 so that confirmation of the diagnosis on CT scan is likely to vary according to local practice. Intracerebral haemorrhages are now being diagnosed with magnetic resonance imaging. 3 Two kinds of decision are required in a patient with an intracerebral haemorrhage: first, how to manage the haematoma, and second, how to prevent rebleeding. The need for measures to prevent rebleeding depends upon aetiology, which is usually clarified by angiography. The prevention of rebleeding is not considered here, but is obviously of great importance, and often influences the management-of the acute haematoma.
Aetiology
Hypertension is the most common cause of intracerebral haemorrhage, and its control is probably the main factor responsible for the decreasing incidence of stroke. 4 Anticoagulation, platelet and coagulation disorders are still common causes of haemorrhage in patients presenting in neurosurgical units. Other causes of spontaneous haemorrhage include the abuse of drugs, particularly those which induce hypertension,5 and acute hypertension in pregnancy and childhood.6 It should never be forgotten that an intracerebral haemorrhage may be the result of a ruptured berry aneurysm. The differentiation of a subarachnoid haemorrhage from an intracerebral haemorrhage is not always possible on clinical grounds alone, and indeed the lesions often coexist on CT scanning. Pasqualin described 309 cases of ICH and showed that the site of the haematoma may help in pointing to the likelihood of an aneurysm,7 although this is less reliable with a large haematoma.8 Arteriovenous malformations are more likely to present with an intracerebral haemorrhage than with a subarachnoid haemorrhage, and should always be considered as a cause, particularly in younger people. Of the tumours that cause intracerebral haemorrhage, metastatic melanoma is one of the commonest.
Pathophysiology
The great majority of haematomas result from rupture of an artery or arteriole and therefore the pressure within the haematoma is initially identical to arterial blood pressure. This increase in pressure causes compression of the surrounding brain parenchyma with resulting ischaemia. Around any haematoma there is an area of complete ischaemia surrounded by an area of oligaemia which is analogous to the penumbra of occlusive stroke. Experimental studies have indicated that the area of ischaemia may be much larger than the haematoma itself.910 The ischaemia is partly the result of mechanical compression of the surrounding microcirculation, although the vasospastic properties of blood probably also play a role." 12 The release of "toxins" from bloods within the haematoma may further aggravate the ischaemia.'3 It has also become clear that rebleeding is associated with a worse prognosis.'4 The damage which may occur around the haematoma may therefore be focal, largely as a result of ischaemia, or global, as a result of reduction in the cerebral perfusion pressure (CPP) which occurs mainly because of rising intracranial pressure. Cerebral perfusion pressure may also fall from the ill-advised treatment of reactive hypertension, particularly if it is due to a Cushing response.
After the initial ischaemic episode, the marginal zone around the haematoma may become oedematous and this in turn may further elevate the intracranial pressure. The use of urokinase to promote liquifacation of the clot before aspiration has also been proposed. 47 The first prospective randomised controlled study to provide evidence that surgical treatment was superior to medical treatment came from Auer et al 48 who reported a mortality of 46% after endoscopic aspiration compared with a mortality of 70% after medical treatment. The high mortality in the medically treated group emphasises the importance of careful matching of patients. Whether these results will be replicated remains to be determined; endoscopy is not in routine use in most neurosurgical units.
Ultimately, progress in management of ICH will depend upon better understanding of the pathophysiological mechanisms leading to damage. ICP measurement in patients with a traumatic intracerebral haematoma predicts the likelihood of subsequent deterioration49 but it is done much less often in spontaneous haematomas. The studies reported to date are largely anecdotal and do not permit a definite statement on the value of ICP monitoring."' There are differences between traumatic and spontaneous haematomas, for example, there is more oedema around a traumatic haematoma52; but also there are many similarities. Lessons learnt about the management of traumatic intracerebral haematomas may be applicable to spontaneous ICH. An understanding of the pathophysiology of spontaneous intracerebral haemorrhage may result in more widespread use of "brain protective agents" which will also have to be subjected to randomised controlled studies.
Conclusion
The increasing availability of CT in district general hospitals and its use in patients with a stroke will highlight the need to establish the best way to manage spontaneous ICH. This information is needed both by specialists in neurosurgery/neurology and by general physicians who, more and more, will need to decide if referral to a neurosurgeon is appropriate.
Unfortunately, at present a definite statement cannot be made about the treatment of many patients with intracerebral haemorrhage. Some clearly warrant surgical evacuation; for others surgical treatment is definitely not indicated (either those with very small haematomas who remain well or those with very large haematomas who are moribund). The uncertainty relates to the patients in the middle of the spectrum and probably the only way to resolve the uncertainties about the treatnent of these patients is to undertake randomised controlled trials of the different forms of therapy. This will hopefully lead to less uncertainties than currently surround the management of spontaneous intracerebral haemorrhage.
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